Keywords: pantec, reports, strong, preclinical, data, please, platform

Pantec reports strong preclinical data on PLEASE platform

Article | 07 April 2008

Pantec Biosolutions AG, a privately-held transdermal drug delivery specialist based in Liechtenstein, has reported promising preclinical in vitro data in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Testosterone

transdermal

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing